The Life Improvement Trial (LIFT)

The Life Improvement Trial (LIFT) aims to investigate two drugs, separately and in combination, Pyridostigmine (commonly known as Mestinon) and Low-Dose Naltrexone (LDN), for efficacy and to research the difference between responders and non-responders.
Investigation into Post-Exertional Malaise Between Historical and Recent ME/CFS

This study explores the biological changes that occur in the muscles during post-exertional malaise (PEM), both in historical cases of ME/CFS and cases of Long COVID that meet the criteria for ME/CFS.
Sleep Disturbance in ME/CFS
We intend to examine multiple sleep studies that have been conducted in the past two years and performed at the MGH Neurology Sleep Medicine Laboratory in well characterized patients with ME/CFS.
Mestinon Clinical Trial

This clinical trial will test the exercise response to Mestinon in people with ME/CFS.
Multi-omics Exercise Intolerance

This project aims to understand the origin of postural orthostatic tachycardia syndrome (POTS).
Heart Preload Failure

This study aims to evaluate different explanations of preload failure in ME/CFS patients.